I
Innocan Pharma Corp
OTC:INNPF
Innocan Pharma Corp
OTC:INNPF
Price:
5.46
USD
Market Closed
Market Cap:
$1.5B
Balance Sheet
Balance Sheet Decomposition
Innocan Pharma Corp
Innocan Pharma Corp
Balance Sheet Decomposition is not available for
Innocan Pharma Corp
Innocan Pharma Corp
Balance Sheet
Innocan Pharma Corp
Innocan Pharma Corp
Currency: USD
| Dec-2017 | Dec-2018 | Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | Dec-2024 | ||
|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||
| Cash & Cash Equivalents |
0
|
0
|
2
|
2
|
11
|
5
|
4
|
5
|
|
| Cash |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
5
|
|
| Cash Equivalents |
0
|
0
|
2
|
2
|
11
|
5
|
4
|
0
|
|
| Total Receivables |
0
|
0
|
0
|
1
|
0
|
0
|
1
|
1
|
|
| Accounts Receivables |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Receivables |
0
|
0
|
0
|
1
|
0
|
0
|
1
|
1
|
|
| Inventory |
0
|
0
|
0
|
0
|
1
|
1
|
2
|
3
|
|
| Other Current Assets |
0
|
0
|
0
|
0
|
1
|
1
|
0
|
0
|
|
| Total Current Assets |
0
|
1
|
2
|
4
|
13
|
7
|
7
|
9
|
|
| PP&E Net |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| PP&E Gross |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Accumulated Depreciation |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Assets |
0
N/A
|
1
+2 100%
|
3
+291%
|
4
+68%
|
13
+190%
|
7
-45%
|
7
-1%
|
9
+33%
|
|
| Liabilities | |||||||||
| Accounts Payable |
0
|
0
|
0
|
1
|
0
|
0
|
0
|
0
|
|
| Accrued Liabilities |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Short-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Current Portion of Long-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Current Liabilities |
0
|
0
|
1
|
7
|
3
|
0
|
2
|
2
|
|
| Total Current Liabilities |
0
|
0
|
1
|
8
|
4
|
1
|
3
|
2
|
|
| Long-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Minority Interest |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
2
|
|
| Other Liabilities |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Liabilities |
0
N/A
|
1
+542%
|
1
+119%
|
8
+579%
|
4
-56%
|
1
-83%
|
3
+387%
|
4
+44%
|
|
| Equity | |||||||||
| Common Stock |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Retained Earnings |
0
|
1
|
5
|
15
|
25
|
28
|
33
|
35
|
|
| Additional Paid In Capital |
0
|
1
|
6
|
11
|
34
|
35
|
37
|
40
|
|
| Other Equity |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Equity |
0
N/A
|
0
N/A
|
1
+1 013%
|
4
N/A
|
9
N/A
|
6
-29%
|
4
-36%
|
5
+26%
|
|
| Total Liabilities & Equity |
0
N/A
|
1
+2 100%
|
3
+291%
|
4
+68%
|
13
+190%
|
7
-45%
|
7
-1%
|
9
+33%
|
|
| Shares Outstanding | |||||||||
| Common Shares Outstanding |
2
|
2
|
2
|
3
|
4
|
4
|
4
|
4
|
|
Switch to:
Switch to:
See Also
Discover More
